The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
1. Objective After single dose in healthy adults the capacity of the Group for DW1029M evaluate the pharmacokinetic characteristics. 2. Indication Diabetic kidney disease 3. Efficacy 1. Primary * AUClast, AUCinf, AUClast/D, AUCinf/D * Cmax, Cmax/D 2. Secondary * Tmax, t1/2, CL/F, Vz/F 4. Safety 1. Adverse Event Monitoring 2. V/S, EKG, Laboratory Test, P/E
Epistemonikos ID: c6ae146a70cbfb17c60392e7c2a13255b44d60da
First added on: May 11, 2024